Hormone replacement therapy in postmeopausal women with coronary artery disease. Results and clinical consequences from recent studies;Hormonsubstitution bei postmenopausalen Frauen mit koronarer Herzkrankheit Ergebnisse und klinische Konsequenzen aus neueren Studien

Wiener Klinische Wochenschrift, Supplement

Volumn , Issue 2, 1997, Pages 42-45

  Schurz, Robert A ^a,c   Benzer, Werner ^b  

^a Abteilung fur Innere Medizin   (Austria)

^b Landeskrankenhaus Feldkirch   (Austria)

^c GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Coronary artery disease; Estrogen replacement therapy; Menopause

Indexed keywords

CHOLESTEROL;

ADULT; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HUMAN; MALE; MENOPAUSE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

ADULT; AGED; CHOLESTEROL; CORONARY CIRCULATION; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0030634612     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Statistisches Jahrbuch für die BRD (1995) Metzler-Poeschl Verlag, Stuttgart
2. World Health Organisation (1988) World Health Statistics Annual 1988. WHO, Geneva
3. National Center for Health Statistics (1993) Vital statistics of the United States 1989. Mortality, Part A. Government Printing Office, Washington DC
4. Bush TL (1990) Noncontraceptive estrogen use and risk of cardiavascular disase: An overview and critique of the literature. In: Korenman SG (ed) The Menopause: Norwell, Mass: Serono Symposia, pp 211-224
5. Stampfer MJ, Colditz GA (1991) Estrogen replacement and coronary heart disease: a qualitative assessment of the epidemiologic evidence. Prev Med 20:47-63
6. Grady D, Rubin SM, Petitti DB (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
7. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willet WC, Rosner B, et al (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335:453-461
8. Wahl P, Walden G, Knopp R (1983) Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med 308:862-867
9. Kushwaha RS, Born KM (1991) Effect of estrogen and progesterone on the hepatic cholesterol 7a-hydroxylase activity in ovariectomized baboons. Biophys Acta 1084:300-302
10. Windler E, Kovanen PT, Chao YS, Brown MS, Havel RJ, Goldstein JL (1980) The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem 225:10464-10471
11. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM (1991) Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
12. Levine GN, Keaney JF, Vita JA (1995) Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 332:512-521
13. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH (1991) Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 325:756-762
14. Zeiher AM, Drexler H, Wollschlager H, Just H (1991) Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stage of coronary atherosclerosis. Circulation 83:391-401
15. Chowienczyk PJ, Watts GF, Cockroft JR, Brett SE, Ritter JM (1994) Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet 334:305-306
16. Williams JK, Adams MR, Klopfenstein HS (1990) Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687
17. Benzer W, Schurz AR, Drexel H (1995) The effect of sublingual oestrogen administration on coronary blood flow in postmenopausal women with coronary artery disease. Eur Heart J 16 [Suppl] 6:387
18. Steinberg D, Parasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
19. Samsioe G (1992) Metabolic effects of reproductive hormons: the lipids. In: Genazziani AR, Petraglia F (eds.) Hormons in gyn. endocrinology. Parthenon Publishing Group, Carnforth, New Jersey, pp 589-600
20. Sacks FM, Pfeffer MA, Lemuel AM, Moye A for the cholesterol and recurrent events trial investigators (1996) The effect of pravastatin on coronary events after myocardial in farction in patients with average cholesterol levels. N Engl J Med 335:1001-1009
21. Guetta V, Cannon III RO (1996) Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 93:1928-1937
22. The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208
23. Husmann F (1994) Kardio- und Vasoprotektion durch Östrogene. J Menopause 2:6-11
24. Collins P (1996) Oestrogens and the cardiovascular system. Europ Menopause Journal 3:276
25. Sarrel PM (1991) Lokale Effekte von Östrogenen auf periphere Gefäße und Blutstrom. Proc Int Novo Nordisk Symp, Kopenhagen. Med Commun Service:81-90
26. Jiang CP, Poole-Wilson A, Sarrel PM (1992) Effekt of 17-beta-oestradiol on contraction, Ca++ current an intracellular free Ca++ in guinea pig isolated cardiac myocytes. Br J Pharmacol 106: 739-745
27. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P (1992) Acute effect of 17-beta-estradiol on rabbit coronary contractile responses to endothelin-1. Am J Physiol 263: H271-275
28. O'Keefe Jjr, Kim SC, Hall RR, Cochran VC, Lawhorn SL (1997) Estrogen replacement therapy after coronary angioplasty in women. JACC 29:1-5
29. Huber J (1995) Klimakterium, Diagnose und Therapie. Berliner Med Verlagsanstalt, Berlin
30. Barrett-Connor E (1991) Postmenopausal estrogen and prevention bias. Ann Intern Med 115:455-456
31. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589-1593
32. Mashchak CA, Lobo RA, Donozo-Takano R (1982) Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 144:511-518